Revenue
$76.2M
▼ 44.8% YoY
Net Income
-$17.4M
▼ 154.5% YoY
EPS
-
Cash
$12.7M
▼ 66.7% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Chu Yu-Waye Chief Medical Officer | Sell | Mar 17, 2026 | 21.3K | $6.42 | $137K | Form 4 ↗ |
McCarthy Sean A. CEO | Sell | Mar 17, 2026 | 119.0K | $6.42 | $764K | Form 4 ↗ |
BELVIN MARCIA SVP, Chief Scientific Officer | Sell | Mar 17, 2026 | 31.5K | $6.42 | $202K | Form 4 ↗ |
Ogden Christopher Chief Financial Officer | Sell | Mar 17, 2026 | 19.3K | $6.42 | $124K | Form 4 ↗ |
Lester Rachael Chief Business Officer | Grant | Feb 2, 2026 | 20.0K | $0.00 | $0 | Form 4 ↗ |
Chu Yu-Waye Chief Medical Officer | Grant | Feb 2, 2026 | 75.0K | $0.00 | $0 | Form 4 ↗ |
BELVIN MARCIA SVP, Chief Scientific Officer | Grant | Feb 2, 2026 | 60.0K | $0.00 | $0 | Form 4 ↗ |
Ogden Christopher Chief Financial Officer | Grant | Feb 2, 2026 | 90.0K | $0.00 | $0 | Form 4 ↗ |
McCarthy Sean A. CEO | Grant | Feb 2, 2026 | 210.0K | $0.00 | $0 | Form 4 ↗ |